Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
[embedyt] https://www.youtube.com/watch?v=ZL8tb5EFlWQ[/embedyt] Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, co-founder, and CEO. In this update to our December 2018 interview, Andy provides an update on the company’s progress into a vertically integrated […]
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, providing an update on the company’s drug development pipeline targeting HIV and cancers, based on CytoDyn’s Leronlimab/PRO 140 platform. […]
CytoDyn, Inc. (OTC: CYDY) Next Super Stock investor conference presentation January 23, 2020 CEO Dr. Nader Pourhassan, Ph.D, discusses CytoDyn’ new $87.5 million licensing deal for commercializing Leronlimab to treat HIV, as well as the […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.